This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1996 Mar;40(3):527-40.

doi: 10.1128/AAC.40.3.527.

Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription

E J Arts¹, M A Wainberg

Affiliations

PMID: 8851566
PMCID: PMC163153
DOI: 10.1128/AAC.40.3.527

Review

Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription

E J Arts et al. Antimicrob Agents Chemother. 1996 Mar.

. 1996 Mar;40(3):527-40.

doi: 10.1128/AAC.40.3.527.

Authors

E J Arts¹, M A Wainberg

Affiliation

¹ McGill University AIDS Centre, Montreal, Quebec, Canada.

PMID: 8851566
PMCID: PMC163153
DOI: 10.1128/AAC.40.3.527

No abstract available

PubMed Disclaimer

Similar articles

Effects of 3'-deoxynucleoside 5'-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA.
Arts EJ, Marois JP, Gu Z, Le Grice SF, Wainberg MA. Arts EJ, et al. J Virol. 1996 Feb;70(2):712-20. doi: 10.1128/JVI.70.2.712-720.1996. J Virol. 1996. PMID: 8551607 Free PMC article.
A novel anticancer agent ARC antagonizes HIV-1 and HCV.
Nekhai S, Bhat UG, Ammosova T, Radhakrishnan SK, Jerebtsova M, Niu X, Foster A, Layden TJ, Gartel AL. Nekhai S, et al. Oncogene. 2007 May 31;26(26):3899-903. doi: 10.1038/sj.onc.1210158. Epub 2006 Dec 18. Oncogene. 2007. PMID: 17173067
Nucleoside spiroxiranes as suicide inhibitors of the human immunodeficiency virus.
Bailey JM, Nelson KA. Bailey JM, et al. Biochem Soc Trans. 1995 Nov;23(4):619S. doi: 10.1042/bst023619s. Biochem Soc Trans. 1995. PMID: 8654804 No abstract available.
L-Nucleosides as chemotherapeutic agents.
Gumina G, Song GY, Chu CK. Gumina G, et al. FEMS Microbiol Lett. 2001 Aug 7;202(1):9-15. doi: 10.1111/j.1574-6968.2001.tb10773.x. FEMS Microbiol Lett. 2001. PMID: 11506901 Review.
Inhibitors of HIV-1 transcription.
Li CJ, Dezube BJ, Biswas DK, Ahlers CM, Pardee AB. Li CJ, et al. Trends Microbiol. 1994 May;2(5):164-9. doi: 10.1016/0966-842x(94)90666-1. Trends Microbiol. 1994. PMID: 8055180 Review.

See all similar articles

Cited by

Lipophilic Nucleoside Triphosphate Prodrugs of Anti-HIV Active Nucleoside Analogs as Potential Antiviral Compounds.
Jia X, Schols D, Meier C. Jia X, et al. Adv Sci (Weinh). 2023 Dec;10(36):e2306021. doi: 10.1002/advs.202306021. Epub 2023 Oct 26. Adv Sci (Weinh). 2023. PMID: 37884485 Free PMC article.
Human immunodeficiency virus type 1 reverse transcriptase: role of Tyr115 in deoxynucleotide binding and misinsertion fidelity of DNA synthesis.
Martín-Hernández AM, Domingo E, Menéndez-Arias L. Martín-Hernández AM, et al. EMBO J. 1996 Aug 15;15(16):4434-42. EMBO J. 1996. PMID: 8861970 Free PMC article.
A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-beta-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine.
Smith RA, Remington KM, Preston BD, Schinazi RF, North TW. Smith RA, et al. J Virol. 1998 Mar;72(3):2335-40. doi: 10.1128/JVI.72.3.2335-2340.1998. J Virol. 1998. PMID: 9499094 Free PMC article.
3'-Azido-3'-deoxythymidine (AZT) mediates cross-resistance to nucleoside analogs in the case of AZT-resistant human immunodeficiency virus type 1 variants.
Arts EJ, Quiñones-Mateu ME, Albright JL, Marois JP, Hough C, Gu Z, Wainberg MA. Arts EJ, et al. J Virol. 1998 Jun;72(6):4858-65. doi: 10.1128/JVI.72.6.4858-4865.1998. J Virol. 1998. PMID: 9573252 Free PMC article.
Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1.
Quiñones-Mateu ME, Albright JL, Mas A, Soriano V, Arts EJ. Quiñones-Mateu ME, et al. J Virol. 1998 Nov;72(11):9002-15. doi: 10.1128/JVI.72.11.9002-9015.1998. J Virol. 1998. PMID: 9765445 Free PMC article.

See all "Cited by" articles

References

1. J Mol Biol. 1994 Oct 28;243(3):369-87 - PubMed
1. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6320-4 - PubMed
1. J Biol Chem. 1992 Feb 25;267(6):3589-96 - PubMed
1. Mutat Res. 1988 Jul-Aug;200(1-2):133-47 - PubMed
1. J Biol Chem. 1986 Dec 5;261(34):16037-42 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database